These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18615093

  • 1. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
    Cournu-Rebeix I, Génin E, Leray E, Babron MC, Cohen J, Gout C, Alizadeh M, Perdry H, Semana G, Brassat D, Clerget-Darpoux F, Yaouanq J, Edan G, Rosenheim M, Fontaine B.
    Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
    [Abstract] [Full Text] [Related]

  • 2. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, Marta M, Freijo M, Costa PP, Mendonça D, Monteiro L, Armas JB, Martins B.
    J Neurol Sci; 2007 Jul 15; 258(1-2):69-74. PubMed ID: 17412364
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR.
    Hum Mol Genet; 2006 Sep 15; 15(18):2813-24. PubMed ID: 16905561
    [Abstract] [Full Text] [Related]

  • 4. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
    Qiu W, Wu JS, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    J Clin Neurosci; 2010 Aug 15; 17(8):1009-13. PubMed ID: 20580995
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, Varney MD, Taylor BV, Foote SJ, ANZgene Consortium, Kilpatrick TJ, Rubio JP.
    Tissue Antigens; 2009 Jul 15; 74(1):17-21. PubMed ID: 19392788
    [Abstract] [Full Text] [Related]

  • 7. HLA-DR15 is associated with lower age at onset in multiple sclerosis.
    Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J.
    Ann Neurol; 2000 Aug 15; 48(2):211-9. PubMed ID: 10939572
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Wu JS, Qiu W, Castley A, James I, Mastaglia FL, Christiansen FT, Carroll WM, Joseph J, Kermode AG.
    Mult Scler; 2010 Jan 15; 16(1):15-20. PubMed ID: 19995849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of the HLA-DRB1*15 allele group and the DRB1*1501 and DRB1*1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    Brum DG, Barreira AA, Louzada-Junior P, Mendes-Junior CT, Donadi EA.
    J Neuroimmunol; 2007 Sep 15; 189(1-2):118-24. PubMed ID: 17681614
    [Abstract] [Full Text] [Related]

  • 13. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar 15; 129(Pt 3):606-16. PubMed ID: 16415308
    [Abstract] [Full Text] [Related]

  • 14. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T.
    J Neurol Sci; 2010 Nov 15; 298(1-2):96-100. PubMed ID: 20810130
    [Abstract] [Full Text] [Related]

  • 15. HLA-DRB1 and month of birth in multiple sclerosis.
    Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC.
    Neurology; 2009 Dec 15; 73(24):2107-11. PubMed ID: 20018638
    [Abstract] [Full Text] [Related]

  • 16. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL, Laherrán E, Gutiérrez F, Martín-Polo J, Iglesias F, Alcázar C, Peralta J, Rostami P.
    Acta Neurol Scand; 2008 Jan 15; 117(1):21-5. PubMed ID: 17883422
    [Abstract] [Full Text] [Related]

  • 17. Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.
    Ganesvaran G, Greer JM, Pender MP.
    Mult Scler; 2009 Jun 15; 15(6):763-6. PubMed ID: 19482865
    [Abstract] [Full Text] [Related]

  • 18. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G, Yeo TW, Goris A, Taylor CJ, Goodman RS, Elian M, Galea-Debono A, Aquilina A, Felice A, Vella M, Sawcer S, Compston DA.
    Neurology; 2008 Jan 08; 70(2):101-5. PubMed ID: 18057318
    [Abstract] [Full Text] [Related]

  • 19. No evidence for an effect of DNA methylation on multiple sclerosis severity at HLA-DRB1*15 or HLA-DRB5.
    Handel AE, De Luca GC, Morahan J, Handunnetthi L, Sadovnick AD, Ebers GC, Ramagopalan SV.
    J Neuroimmunol; 2010 Jun 08; 223(1-2):120-3. PubMed ID: 20394989
    [Abstract] [Full Text] [Related]

  • 20. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
    Zivković M, Stanković A, Dincić E, Popović M, Popović S, Raicević R, Alavantić D.
    Clin Chim Acta; 2009 Aug 08; 406(1-2):27-30. PubMed ID: 19433080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.